• Skip to main content
  • Skip to secondary menu
  • Skip to footer

OPINT

OPINT stands for Operational Intelligence

  • About
    • GDPR
  • Sponsored Post
    • Make a Contribution
  • Job Board
  • Contact

Avellino Surpasses Two Million COVID-19 Tests in United States

June 28, 2021 By admin Leave a Comment

Company’s SARS-CoV-2/COVID-19 Test (AvellinoCoV2) – One of the First COVID-19 Tests to Receive EUA – Continues to Play Critical Role in Public Health Efforts

MENLO PARK, Calif. – Avellino Lab USA, Inc. (Avellino) today announced that more than two million of its SARS-CoV-2/COVID-19 tests (AvellinoCoV2) have now been performed in the United States.

Avellino was one of the first private companies in the U.S. to receive an Emergency Use Authorization (EUA) from the FDA for AvellinoCoV2 in March 2020. The test provided much-needed testing capacity during the initial surge of the pandemic in the U.S., in particular among populations in skilled nursing facilities, schools, colleges and government municipalities.

The AvellinoCoV2 test targets the N-gene region of the SARS-CoV-2 virus, which has so far proven to be less prone to mutations seen in COVID-19 variants, helping to prevent false negatives that can occur when targeting areas of the virus that are more susceptible to mutations.

Further supporting local and national public health efforts, Avellino received an EUA in November 2020 for its COVID-19/Flu AvellinoCoV2 Respiratory test, which is designed to differentiate between COVID-19 and the various types of influenza viruses.

For both the AvellinoCoV2 and AvellinoCoV2-Respiratory tests, Avellino processes the tests in the company’s high complexity CLIA-certified lab. The lab can process tens of thousands of tests a day, with further plans to continually increase capacity. This focus on increased capacity helped enable Avellino to quickly respond to the pandemic.

“Just prior to COVID-19, we had begun a limited rollout of our first genetic eye test, AvaGen; however, with the onset of COVID-19, we were able to apply our complex genetic expertise to focus on a novel molecular viral test, navigate the regulatory pathway, modify our CLIA-certified lab and scale rapidly,” said Avellino CEO Jim Mazzo.

He continued, “We have since resumed the launch of our genetic eye test; however, we recognize that COVID-19 may be with us for the long-term, and our respiratory portfolio remains needed and valuable. With SARS-CoV-2 continuing to mutate and respiratory infections prevalent every fall, no one knows how COVID-19 may continue to affect us in the future. What we do know is that we have a talented and nimble team that has demonstrated they are up for the toughest challenges in health.”

Avellino possesses genome sequencing capabilities, which can help in the efforts to track the spread of emerging SARS-CoV-2 variants. Data from this sequencing is reported to the CDC as part of its SPHERES program (SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance), which is aimed at coordinating sequencing efforts nationally in support of larger COVID-19 mitigation efforts.

About Avellino
Avellino Lab USA, Inc. is a global leader in gene therapy and molecular diagnostics at the forefront of precision medicine for eye care. With a long-term mission to develop personalized approaches to improve health and disease management through genomics, the company is developing a transformative genetic diagnostics product pipeline, as well as genetic therapeutics leveraging CRISPR gene editing, to better manage, and potentially cure, inherited diseases. The company also developed the Avellino SARS-CoV-2 RT-PCR diagnostic test to aid in COVID-19 pandemic testing efforts in the US, and was the third private company in the nation to receive EUA for its COVID-19 test. Avellino is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.

To learn more about Avellino, visit www.avellino.com.

Filed Under: News Tagged With: COVID-19, biotech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • “Buy” Recommendation: Cloudflare Positioned for Sustained Growth and Profitability
  • Navigating the Expanding World of Cybersecurity with CybersecurityMarket.com
  • A New Front Opens: North Korea Joins Russia’s War Effort
  • South Korea’s Innovation Showcase: 24 Startups Take Center Stage at TechCrunch Disrupt 2024
  • Spain’s Digital Nomad Visa: A Gateway to a Work-Life Adventure in the Sun
  • Smartoptics enters long-term partnership with US technology solutions provider WIN Technology
  • The Ever-Present Challenge: Why Cybersecurity Remains a Critical Concern
  • European Shoppers Cut Spending Despite Easing Inflation, BCG Survey Finds
  • APA Poll Reveals Future of Nation, Economy, and 2024 Election as Leading Stressors for Americans
  • Gartner Identifies the Top 10 Strategic Technology Trends for 2025

Media Partners

  • Cybersecurity Market
  • Media Partners
Kenzo Security Unveils Its Agentic AI Vision: A Swarm Intelligence Approach to Security Operations
Octane Raises $6.75 Million to Bolster Blockchain Security with AI
Rubrik Named Leader in Gartner Magic Quadrant, Fuels Cyber Resilience with Agentic AI
Arsen Launches AI-Powered Vishing Simulation to Help Organizations Combat Voice Phishing at Scale
SquareX Discloses Browser-Native Ransomware that Puts Millions at Risk
Guardz Raises $56M Series B to Scale AI-Native Cybersecurity Platform for MSPs and SMBs
SpyCloud Research Shows that Endpoint Detection and Antivirus Solutions Miss Two-Thirds (66%) of Malware Infections
Halcyon’s TRIP: A Global Bounty Against Ransomware
Stratodesk Advances Industrial Automation with Secure NoTouch OS for IIoT
General Dan Caine Headlines Cybersecurity Gathering in Washington Amid Rising Threat Landscape
Opinion
Media Instances
Studio Tel Aviv
Sharp Knife
Peppers
OSINT
Posters
Israel News
App Coding
Press Club

Media Partners

  • Defense Market
  • Media Partners
World’s First Person-on-the-Move BGAN Terminal Unveiled for Militaries and Emergency Services
Bahrain International Airshow putting defence in the spotlight
US Navy Awards L3Harris $587 Million Contract for Next Generation Jammer – Low Band Program
Saronic Secures $175 Million in Series B Funding, Reaches $1 Billion Valuation
AeroVironment Q3 Fiscal 2025 Report: Navigating Challenges and Paving a Strategic Future
Elbit Systems Secures $340 Million Ammunition Supply Contract with Israeli Ministry of Defense
Leonardo DRS Awarded $26 Million Contract from NAVSEA for AN/SPQ-9B Radar Services
FARNBOROUGH International: Belgium’s Aerospace & Defence companies team up with UK Industry — Booth #1157
The U.S. Air Force unveiled the B-21 Raider Friday in Palmdale, California
Anduril Industries Reaches $14 Billion Valuation in Latest Funding Round, Pioneering the Future of Defense Technology
Passerby
Technologies
Studio Tel Aviv
Media Presser
Dossier
VPNW
Photo Studio
Virtual Travel Guide
Analysis
Opint

Copyright © 2022 OPINT.com